AJP - Endo Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab 234: E375-E378, 1978;
0193-1849/78 $5.00
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yamagishi, T
Right arrow Articles by Debas, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yamagishi, T
Right arrow Articles by Debas, H.
AJP: Endocrinology and Metabolism, Vol 234, Issue 4, E375-E378
Copyright © 1978 by American Physiological Society

ARTICLES

Cholecystokinin inhibits gastric emptying by acting on both proximal stomach and pylorus

T Yamagishi and HT Debas

Cholecystokinin is a potent inhibitor of gastric emptying. It is known to both relax the proximal stomach and contract the pyloric sphincter, and either one or both of these actions could mediate inhibition of gastric emptying. We investigated the relative importance of these two actions by studying the effectiveness of the C-terminal octapeptide of cholecystokinin (OP-CCK) to inhibit the emptying of a liquid meal (300 ml saline) before and after operations that either remove or destroy the pyloric mechanism (antrectomy and pyloroplasty), or lead to loss of accommodation of the proximal stomach (vagotomy), and after both vagotomy and antrectomy, and vagotomy and pyloroplasty. The results show that OP-CCK causes dose-related inhibition of gastric emptying in the intact dog. After either pyloroplasty or antrectomy the effectiveness of low but not of high doses of OP-CCK is lost. After vagotomy, OP-CCK at any dose was ineffective. The findings suggest that cholecystokinin inhibits gastric emptying by acting both on the pylorus and on the proximal stomach.


This article has been cited by other articles:


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
T. J. Little, K. L. Feltrin, M. Horowitz, J. H. Meyer, J. Wishart, I. M. Chapman, and C. Feinle-Bisset
A high-fat diet raises fasting plasma CCK but does not affect upper gut motility, PYY, and ghrelin, or energy intake during CCK-8 infusion in lean men
Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2008; 294(1): R45 - R51.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
D. W. Adelson, M. Million, K. Kanamoto, T. Palanca, and Y. Tache
Coordinated gastric and sphincter motility evoked by intravenous CCK-8 as monitored by ultrasonomicrometry in rats
Am J Physiol Gastrointest Liver Physiol, February 1, 2004; 286(2): G321 - G332.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online